Which variables are associated with pain intensity and treatment response in advanced cancer patients?--Implications for a future classification system for cancer pain.
about
What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert OpinionDifferences between opioids: pharmacological, experimental, clinical and economical perspectivesManagement of breakthrough pain in children with cancer.Clinical and genetic factors related to cancer-induced bone pain and bone pain relief.Trajectories of pain and analgesics in oncology outpatients with metastatic bone pain during participation in a psychoeducational intervention study to improve pain management.Symptoms Reported by Head and Neck Cancer Patients during Radiotherapy and Association with Mucosal Ulceration Site and Size: An Observational StudyAssociations between pro- and anti-inflammatory cytokine genes and breast pain in women prior to breast cancer surgeryCharacteristics and associations of pain intensity in patients referred to a specialist cancer pain clinic.Analgesia and central side-effects: two separate dimensions of morphine response.Gender, variation in opioid receptor genes and sensitivity to experimental pain.Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials.Managing difficult pain conditions in the cancer patient.Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain.Pain in blood cancers.Depressed patients with incurable cancer: which depressive symptoms do they experience?Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study.Opioid treatment failure in cancer patients: the role of clinical and genetic factors.A cross-sectional study on prevalence of pain and breakthrough pain among an unselected group of outpatients in a tertiary cancer clinic.Efficacy and safety of pregabalin in patients with neuropathic cancer pain undergoing morphine therapy.The Edmonton Symptom Assessment System: Poor performance as screener for major depression in patients with incurable cancer.Morning types are less sensitive to pain than evening types all day long.Ask The Experts: Critical issues in cancer pain management.A systematic review of the risk factors for clinical response to opioids for all-age patients with cancer-related pain and presentation of the paediatric STOP pain study.The Palliative Radiotherapy and Inflammation Study (PRAIS) - protocol for a longitudinal observational multicenter study on patients with cancer induced bone pain
P2860
Q28069133-3CED93A7-15D1-4F2C-B7FB-E42596934FF3Q34272502-8C9964E2-301F-4414-863A-985D6789F3F1Q34410657-92E56DBD-1C2B-4D3E-863B-4CB23A8F9DFCQ34641014-E4F18FC6-02BF-4938-93A7-F288178A67A5Q35036818-C40DAA7F-A0B9-406C-A69F-62C398E713E3Q35659390-E2A19114-2D5C-482F-BA23-82F5F83C294AQ35946872-189B1905-281C-444B-8112-E490630D2DA3Q36132137-513D0613-6ADD-43C6-8E6A-CC3E48197289Q36792999-AD5253B8-6ECC-488B-B1BC-BAFDF8D3ED7CQ36794010-CBEE78D0-E65B-4B4E-A000-E7C8054B5778Q37536304-F490257B-D434-45A6-99A4-0442F77BFA23Q38177185-EE244B0F-21BC-4E14-8952-E82F71B36CCEQ39199034-73C799AE-E168-4846-8B48-68DB599AD547Q39251577-D6D26379-D30B-47BA-8AB0-3F521FE6DD21Q39471599-3B3A0049-7E5B-4B10-BEEA-A19763D9053DQ44003528-B4130ECC-7617-4918-930D-4FF2D33F1743Q44339058-2959634B-F65A-4B5E-8C19-ACFD08AD5EA6Q45213227-46C63EA2-096B-4EAB-9F08-1245731E1350Q48006336-C6DA935C-8553-4EA6-9C83-169DAE72645CQ48066480-C54B68A9-BFF1-4CAB-8335-CCBFACB4EEA2Q48200268-AE037720-2A65-4277-A685-376C01469B11Q50948761-BFB56BB5-BFE2-463B-BCE5-A73E0FF48648Q54943506-BE8F595B-2D95-4C89-9DE6-35E78B200227Q59126052-527AB744-990B-4FE8-827F-BF34960ABCEC
P2860
Which variables are associated with pain intensity and treatment response in advanced cancer patients?--Implications for a future classification system for cancer pain.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Which variables are associated ...... cation system for cancer pain.
@en
Which variables are associated ...... cation system for cancer pain.
@nl
type
label
Which variables are associated ...... cation system for cancer pain.
@en
Which variables are associated ...... cation system for cancer pain.
@nl
prefLabel
Which variables are associated ...... cation system for cancer pain.
@en
Which variables are associated ...... cation system for cancer pain.
@nl
P2093
P2860
P50
P1476
Which variables are associated ...... cation system for cancer pain.
@en
P2093
Anne Kari Knudsen
European Palliative Care Research Collaborative
European Pharmacogenetic Study
Mauro Montanari
Oscar Corli
P2860
P304
P356
10.1016/J.EJPAIN.2010.08.001
P577
2010-09-06T00:00:00Z